Lower Pharma Tariffs for the UK

Effective July 31, 2026, patented Pharmaceutical products from the United Kingdom will be subject to Section 232 Pharma duties. Additionally, associated ingredients that are products of the UK fall under the same assessment. The duties are assessed at 0 percent.

The new rate is lower than the 10% stated in the CSMS notice. This CSMS notice from U.S. Customs and Border Protection (CBP) was issued days prior. The reduced tariff is applied by using Harmonized Tariff Schedule number 9903.04.63.

9903.04.63: Applies to patented pharmaceutical articles that are the product of the United Kingdom as defined in subdivisions (c) and (g) of U.S. note 40 to subchapter III.   

Additional Information

Federal Register :: Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020

CSMS # 69395344 – GUIDANCE: Section 232 Duties on Imports of Patented Pharmaceutical Articles and Ingredients

Questions?

We’re Here to Help – Reach Out to Your NNR Representative